STOCK TITAN

IMA Medical Group Signs Agreement with MedAvail to Open Four SpotRx Locations in Florida

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

MedAvail Holdings (Nasdaq: MDVL) is set to launch four SpotRx pharmacy kiosks within IMA Medical Group clinics in Florida starting in 2021. This collaboration aims to enhance medication access for Medicare patients, providing in-clinic prescriptions and free next-day home deliveries. Patients will benefit from follow-up calls from pharmacists and refill reminders for chronic medications. This initiative expands MedAvail's footprint in Florida by utilizing the MedAvail MedCenter technology, aligning with IMA's commitment to quality patient care.

Positive
  • Expansion of SpotRx pharmacy kiosks in Florida clinics enhances accessibility to medications for Medicare patients.
  • Partnership with IMA Medical Group strengthens MedAvail's presence in the Florida market.
  • In-clinic access and free home delivery may improve patient adherence to medications.
Negative
  • None.

Innovative self-serve pharmacy kiosks to be embedded in four clinics

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)-- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company, expects to open an initial four SpotRx locations in 2021 with IMA Medical Group in Florida.

In-clinic SpotRx kiosks and courier home delivery will be available to patients at four IMA Medical clinic locations in central Florida. SpotRx Pharmacy is the retail pharmacy brand owned and operated by MedAvail in the United States, which deploys and operates the MedAvail MedCenters.

“We are pleased to partner with the IMA group, broadening our footprint in Florida with the addition of this growing network of clinics that provides exceptional care to Medicare patients,” said Ed Kilroy, Chief Executive Officer of MedAvail. “We look forward to offering the convenience of our pharmacy services to IMA’s Medicare patients and continuing our efforts in Florida to address medication access and adherence.”

IMA Medical Group is an independent provider of high-quality primary medical and wellness services in Central Florida. SpotRx's interactive kiosks provide IMA patients easy, in-clinic access to prescription medications.

With the SpotRx embedded pharmacy model, IMA patients will receive:

  • Immediate access to prescriptions at the four IMA wellness centers
  • Free contactless next-day home delivery for all prescriptions and over-the-counter medications
  • Follow up care calls from a local SpotRx pharmacist after receiving the prescription
  • Refill reminder calls on all chronic medications to schedule free delivery or in-clinic pickup
  • Instant access to SpotRx pharmacists via kiosk or phone

“IMA provides high quality, patient-centered primary care to the patients we serve,” said Dr. Mark Leenay, Chief Executive Officer of IMA Medical Group. “We are continuously assessing our programs to ensure that we are providing the highest standards of care to our patients. To that end, we are excited about our innovative partnership with SpotRx to embed pharmacies directly into our clinics as part of a continued expansion of services within our health centers.”

About IMA Medical Group

IMA Medical Group provides high quality primary medical and wellness services focusing on improving patient care, reducing costs, and offering convenient services for patients, their families and caregivers. Headquartered in Orlando, Florida, IMA serves patients in 21 medical centers across Central Florida including Orlando, Lakeland, Davenport, Winter Haven, Lake Wales, Clermont, Oviedo, Kissimmee, St. Cloud, and Tampa, where over 70 physicians and nurse practitioners provide comprehensive medical services to over 40,000 members in partnership with all leading Medicare Health Plans. For more information, please visit www.imamedicalgroup.com.

About SpotRx

SpotRx places control of the pharmacy experience back in the hands of consumers. SpotRx is a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery capability.

About MedAvail

MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

SOURCE MedAvail Holdings Inc.

Investor Relations

Caroline Paul

Gilmartin Group

ir@medavail.com

Source: MedAvail Holdings Inc.

FAQ

What is the significance of the new SpotRx locations for MedAvail (MDVL)?

The new SpotRx locations represent an expansion of MedAvail's services, enhancing access to medications for Medicare patients in Florida.

When will MedAvail's SpotRx kiosks be available in Florida?

The SpotRx kiosks are expected to open in 2021.

How will the partnership with IMA Medical Group benefit patients?

Patients will have immediate access to prescriptions, free next-day home delivery, and follow-up care from pharmacists.

What technology does MedAvail use in its pharmacy services?

MedAvail utilizes its proprietary robotic dispensing platform, the MedAvail MedCenter, to provide pharmacy services.

MedAvail Holdings, Inc.

NASDAQ:MDVL

MDVL Rankings

MDVL Latest News

MDVL Stock Data

2.91M
380.04k
0.38%
87.06%
0.64%
Pharmaceutical Retailers
Healthcare
Link
United States
Phoenix